J Korean Med Sci.  2014 Mar;29(3):334-337. 10.3346/jkms.2014.29.3.334.

The Reliability and Validity of a Korean Translation of the ASAS Health Index and Environmental Factors in Korean Patients with Axial Spondyloarthritis

• Choi JH
• Kim TJ
• Shin K
• Choi CB
• Kim JH
• Kim SH
• Kim NI
• Ahn MJ
• Jung HJ
• Lee KE
• Park DJ
• Park YW
• Lee SS
• Kim TH

• KMID: 1734918
• DOI: http://doi.org/10.3346/jkms.2014.29.3.334

Abstract

The objective of this study was to develop a Korean version of the Assessment of Spondyloarthritis International Society-Health Index/Environmental Factor (ASAS HI/EF) and to evaluate its reliability and validity in Korean patients with axial spondyloarthritis (SpA). A total of 43 patients participated. Translation and cross-cultural adaptation of the ASAS HI/EF was performed according to international standardized guidelines. We also evaluated validity by calculating correlation coefficients between the ASAS-HI/EF score and the clinical parameters. Test-retest reliability was excellent. The correlations among the mean ASAS-HI score and all tools of assessment for SpA were significant. When it came to construct validity, the ASAS HI score was correlated with nocturnal back pain, spinal pain, patients's global assessment score, the Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI), Bath ankylosing spondylitis metrology index (BASMI) and EuroQoL visual analogue scale (EQ VAS) (r = 0.353, 0.585, 0.598, 0.637, 0.690, 0.430, and -0.534). The ASAS EF score was also correlated with the patient's global assessment's score, BASDAI, BASFI, BASMI, and EQ VAS score (r = 0.375, 0.490, 0.684, 0.485, and -0.554). The Korean version of the ASAS HI/EF can be used in the clinical field to assess and evaluate the state of health of Korean axial SpA patients.

Keyword

Spondylitis, Ankylosing; Spondylarthropathies; Validation Studies

MeSH Terms

Adult
Asian Continental Ancestry Group
Female
Guidelines as Topic
Humans
Interviews as Topic
Male
Middle Aged
Questionnaires
Reproducibility of Results
Republic of Korea
*Severity of Illness Index
Spondylitis, Ankylosing/*diagnosis/physiopathology
Translations

Reference

1. Khan MA, van der Linden SM. A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum. 1990; 20:107–113.

2. Dougados M, Gueguen A, Nakache JP, Nguyen M, Amor B. Evaluation of a functional index for patients with ankylosing spondylitis. J Rheumatol. 1990; 17:1254–1255.

3. Ruof J, Stucki G. Comparison of the dougados functional index and the Bath Ankylosing Spondylitis Functional Index: a literature review. J Rheumatol. 1999; 26:955–960.

4. Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, Maksymowych W, Kostanjsek N, Cieza A, Stucki G, van der Heijde D. ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis. 2010; 69:102–107.

5. Kiltz U, van der Heijde D, Cieza A, Boonen A, Stucki G, Ustün B, Braun J. Developing and validating an index for measuring health in patients with ankylosing spondylitis. Rheumatology (Oxford). 2011; 50:894–898.

6. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009; 68:777–783.

7. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27:361–368.

8. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994; 21:2286–2291.

9. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994; 21:2281–2285.

10. Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A. A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol. 1995; 22:1609.

11. Zochling J, Braun J. Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2007; 21:699–712.

12. Kim MH, Cho YS, Uhm WS, Kim S, Bae SC. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res. 2005; 14:1401–1406.

13. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000; 25:3186–3191.

14. Van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis: assessments in Ankylosing Spondylitis Working Group. J Rheumatol. 1997; 24:2225–2229.

15. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33:337–343.